Tema Launches Healthcare AI ETF Targeting $9 Trillion Market
Event summary
- Tema ETFs launched the Healthcare AI ETF (HLTH) on July 21, 2026, targeting companies leveraging AI in drug discovery, diagnostics, and clinical applications.
- The fund is managed by Dr. David Song, a Yale and Penn-trained physician with over two decades of healthcare investing experience.
- U.S. healthcare spending is forecast to reach $9 trillion by 2034, but the sector accounts for just 8.9% of the S&P 500 as of June 30, 2026.
- HLTH has a gross expense ratio of 0.75% and is listed on NASDAQ.
The big picture
Tema’s launch of HLTH comes as AI investment cycles broaden beyond semiconductor infrastructure, with healthcare emerging as a key adoption market. The fund targets a sector where AI can compress decades of biological progress into years, backed by significant private investment. With U.S. healthcare spending projected to surpass $9 trillion by 2034, HLTH positions itself to capitalize on the underappreciated potential of AI-driven innovation in the industry.
What we're watching
- AI Adoption Pace
- How quickly AI technologies like DeepMind’s AlphaFold transition from research to widespread clinical adoption.
- Market Penetration
- Whether HLTH can capture significant AUM given the underappreciated market potential of AI in healthcare.
- Regulatory Risks
- The impact of government regulations and reimbursement policies on the profitability of healthcare AI companies.
Related topics